Pin1 deficiency causes endothelial dysfunction and hypertension

Hypertension

Volumn 58, Issue 3, 2011, Pages 431-438

  Chiasson, Valorie L ^a   Munshi, Nidhi ^a   Chatterjee, Piyali ^a   Young, Kristina J ^a   Mitchell, Brett M ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Endothelium; experimental; hypertension; NO synthase; phosphorylation; Pin1

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; JUGLONE; NITRIC OXIDE; PEPTIDYLPROLYL ISOMERASE PIN1; SERINE; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EX VIVO STUDY; HYPERTENSION; HYPOTHESIS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; ISOMERISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RAT;

AMINO ACID SUBSTITUTION; ANIMALS; AORTA; BINDING SITES; BLOOD PRESSURE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERTENSION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NAPHTHOQUINONES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN BINDING; RATS; RNA INTERFERENCE; SERINE; VASODILATION;

EID: 80051923030     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.172338     Document Type: Article

References (23)

1. Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signaling and disease. Nat Rev Mol Cell Biol. 2007;8: 904-916. (Pubitemid 47622559)
2. Lu KP, Finn G, Lee TH, Nicholson LK. Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol. 2007;3:619-629. (Pubitemid 47417709)
3. Lu KP. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell. 2003;4:175-180. (Pubitemid 37163831)
4. Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 1999;399:784-788. (Pubitemid 29293174)
5. Shen ZJ, Esnault S, Malter JS. The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nature Immunol. 2005;6:1280-1287. (Pubitemid 43045640)
6. Esnault S, Braun RK, Shen ZJ, Xiang Z, Heninger E, Love RB, Sandor M, Malter JS. Pin1 modulates the Type 1 immune response. PLoS One. 2007;2:e226.
7. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recipient-Part II: Immunosuppressive drugs. Circulation. 2004;110: 3858-3865. (Pubitemid 40023985)
8. Lindenfeld J, Page RL, Zolty R, Shakar SF, Levi M, Lowes BD, Wolfel EE, Miller GG. Drug therapy in the heart transplant recipient-part III: common medical problems. Circulation. 2005;111:113-117. (Pubitemid 40070852)
9. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure: Collaborative Transplant Study. Kidney Int. 1998;53:217-222. (Pubitemid 28066925)
10. Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283:633-638. (Pubitemid 30069179)
11. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus for immunosuppression in liver transplantation. N Engl J Med. 1994;331:1110-1115.
12. Long C, Cook LG, Hamilton SL, Wu GY, Mitchell BM. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension. 2007; 49:569-576.
13. Long C, Cook LG, Wu GY, Mitchell BM. Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2007;27: 1580-1586. (Pubitemid 46986113)
14. Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 2002;416:334-337. (Pubitemid 34260249)
15. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther. 2001;299:818-824. (Pubitemid 33104947)
16. Ruan L, Torres CM, Qian J, Chen F, Mintz JD, Stepp DW, Fulton D, Venema RC. Pin1 prolyl isomerase regulates endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2011;31:392-398.
17. Atchison FW, Capel B, Means AR. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development. 2003;130: 3579-3586. (Pubitemid 37010020)
18. Li C, Ruan L, Sood SG, Papapetropoulos A, Fulton D, Venema RC. Role of eNOS phosphorylation at Ser-116 in regulation of eNOS activity in endothelial cells. Vascul Pharmacol. 2007;47:257-264. (Pubitemid 350017809)
19. Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, Grabley S, Kullertz G, Fischer G. Selective inactivation of parvulin-like peptidylprolyl cis/trans isomerases by juglone. Biochemistry. 1998;37: 5953-5960. (Pubitemid 28196748)
20. Siepe D, Jentsch S. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation. Nat Cell Biol. 2009;11:967-972.
21. Liu T, Huang Y, Likhotvorik RI, Keshvara L, Hoyt DG. Protein never in mitosis gene A interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells. Am J Physiol Cell Physiol. 2008;295:C819-C827.
22. Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003;63:6244-6251. (Pubitemid 37255170)
23. Tong X, Li H. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Lett. 2004;210:63-71. (Pubitemid 38692589)